CLINICAL_TRIALS
trial_result
· 2015-12-22
Clinical Trial Update: Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin [Phase 1]
Summary
Phase 1 study evaluating the effect of BIA 9-1067 on the pharmacokinetics and pharmacodynamics of warfarin in Parkinson's disease patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: COMPLETED | Results posted: 2015-12-22